封面
市場調查報告書
商品編碼
1387493

血糖監測系統市場報告:2030 年趨勢、預測與競爭分析

Blood Glucose Monitoring System Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

血糖監測系統的趨勢和預測

預計到 2030 年,全球血糖監測系統市場將達到 345 億美元,2024 年至 2030 年年複合成長率為 7.5%。該市場的主要促進因素是糖尿病盛行率的增加、高齡化導致的糖尿病易感性增加、新產品的發布以及糖尿病預防意識的提高。全球血糖監測系統市場的未來充滿希望,指尖和替代站點市場存在機會。

血糖監測系統市場洞察

Lucintel 預測,由於糖尿病患者數量不斷增加以及人們對定期監測血糖水平的意識不斷增強,居家照護在預測期內仍將是最大的細分市場。

由於肥胖率上升、醫療成本高、新產品推出和技術改進,北美在預測期內將繼續成為最大的地區。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球血糖監測系統市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球血糖監測系統市場趨勢(2018-2023)與預測(2024-2030)
  • 按測試地點分類的全球血糖監測系統市場
    • 指尖
    • 替代網站
  • 全球血糖監測系統市場(按產品)
    • 自我監控
    • CGMS
  • 按患者照護的全球血糖監測系統市場
    • 醫院
    • 居家照護
  • 全球血糖監測系統市場(按應用)
    • 類型1
    • 2型
    • 妊娠糖尿病
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球血糖監測系統市場(按地區)
  • 北美血糖監測系統市場
  • 歐洲血糖監測系統市場
  • 亞太地區血糖監測系統市場
  • 其他地區血糖監測系統市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按測試地點分類的全球血糖監測系統市場的成長機會
    • 全球血糖監測系統市場成長機會(按產品)
    • 患者照護的全球血糖監測系統市場成長機會
    • 全球血糖監測系統市場成長機會(按應用)
    • 全球血糖監測系統市場成長機會(按地區)
  • 全球血糖監測系統市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球血糖監測系統市場的產能
    • 全球血糖監測系統市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
簡介目錄

Blood Glucose Monitoring System Trends and Forecast

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

A more than 150-page report is developed to help in your business decisions.

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Shipment Analysis by Value from 2018 to 2030]:

  • Fingertip
  • Alternate Site

Blood Glucose Monitoring System Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Self-Monitoring
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Homecare

Blood Glucose Monitoring System Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Type 1
  • Type 2
  • Gestational Diabetes
  • Others

Blood Glucose Monitoring System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Blood Glucose Monitoring System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies blood glucose monitoring system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Blood Glucose Monitoring System Market Insights

Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing site, product, patient care setting, application, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the blood glucose monitoring system market size?

Answer: The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030.

Q2. What is the growth forecast for blood glucose monitoring system market?

Answer: The global blood glucose monitoring system market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the blood glucose monitoring system market?

Answer: The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

Q4. What are the major segments for blood glucose monitoring system market?

Answer: The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets.

Q5. Who are the key blood glucose monitoring system market companies?

Answer: Some of the key blood glucose monitoring system companies are as follows:

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which blood glucose monitoring system market segment will be the largest in future?

Answer: Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

Q7. In blood glucose monitoring system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Blood Glucose Monitoring System Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Blood Glucose Monitoring System Market by Testing Site
    • 3.3.1: Fingertip
    • 3.3.2: Alternate Site
  • 3.4: Global Blood Glucose Monitoring System Market by Product
    • 3.4.1: Self-Monitoring
    • 3.4.2: Continuous Glucose Monitoring Devices
  • 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 3.5.1: Hospital
    • 3.5.2: Homecare
  • 3.6: Global Blood Glucose Monitoring System Market by Application
    • 3.6.1: Type 1
    • 3.6.2: Type 2
    • 3.6.3: Gestational Diabetes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Blood Glucose Monitoring System Market by Region
  • 4.2: North American Blood Glucose Monitoring System Market
    • 4.2.2: North American Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.3: European Blood Glucose Monitoring System Market
    • 4.3.1: European Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.3.2: European Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.4: APAC Blood Glucose Monitoring System Market
    • 4.4.1: APAC Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.4.2: APAC Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.5: ROW Blood Glucose Monitoring System Market
    • 4.5.1: ROW Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.5.2: ROW Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
    • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
    • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
    • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
  • 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott